Eribulin is an anti-cancer ("antineoplastic" or "cytotoxic") chemotherapy drug. This medication is classified as a "non-taxane microtubule inhibitor" treat patients with metastatic breast cancer who have received at least two prior chemotherapy regimens for late-stage disease, including both anthracycline- and taxane - Eribulin is also for use in a variety of other solid tumors, including non-small cell lun cancer, prostate cancer and sarcoma.
Vial
3375 EGP
Eribulin is an anti-cancer ("antineoplastic" or "cytotoxic") chemotherapy drug. This medication is classified as a "non-taxane microtubule inhibitor" treat patients with metastatic breast cancer who have received at least two prior chemotherapy regimens for late-stage disease, including both anthracycline- and taxane - Eribulin is also for use in a variety of other solid tumors, including non-small cell lun cancer, prostate cancer and sarcoma.
Note: All the provided information about this drug does not substitute for consulting a doctor.